Trade-Ideas LLC identified

ICU Medical



) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified ICU Medical as such a stock due to the following factors:

  • ICUI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $10.1 million.
  • ICUI has traded 11.089600000000000790123522165231406688690185546875 options contracts today.
  • ICUI is making at least a new 3-day high.
  • ICUI has a PE ratio of 38.
  • ICUI is mentioned 0.61 times per day on StockTwits.
  • ICUI has not yet been mentioned on StockTwits today.
  • ICUI is currently in the upper 20% of its 1-year range.
  • ICUI is in the upper 35% of its 20-day range.
  • ICUI is in the upper 45% of its 5-day range.
  • ICUI is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ICUI with the Ticky from Trade-Ideas. See the FREE profile for ICUI NOW at Trade-Ideas

More details on ICUI:

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. ICUI has a PE ratio of 38. Currently there are 3 analysts that rate ICU Medical a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for ICU Medical has been 104,300 shares per day over the past 30 days. ICU Medical has a market cap of $1.9 billion and is part of the health care sector and health services industry. The stock has a beta of 0.32 and a short float of 3.6% with 4.95 days to cover. Shares are up 3.5% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.


TheStreet Quant Ratings

rates ICU Medical as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

Highlights from the ratings report include:

  • ICUI's revenue growth has slightly outpaced the industry average of 4.8%. Since the same quarter one year prior, revenues rose by 10.3%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • ICUI has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 12.92, which clearly demonstrates the ability to cover short-term cash needs.
  • Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period. Although other factors naturally played a role, the company's strong earnings growth was key. Looking ahead, unless broad bear market conditions prevail, we still see more upside potential for this stock, despite the fact that it has already risen over the past year.
  • ICU MEDICAL INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, ICU MEDICAL INC increased its bottom line by earning $2.74 versus $1.69 in the prior year. This year, the market expects an improvement in earnings ($4.42 versus $2.74).
  • The gross profit margin for ICU MEDICAL INC is rather high; currently it is at 60.13%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 17.69% is above that of the industry average.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.